Status:
COMPLETED
Home Evaluation of Exit Barriers in Wandering
Lead Sponsor:
US Department of Veterans Affairs
Conditions:
Dementia, Alzheimer Type
Problem Behavior
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
Main hypothesis. Floor and door visual exit barriers will decrease exit-seeking wandering (exit door approaches) proximal to exit doorways by persons with dementia who wander.
Detailed Description
Introduction: Wandering behavior is manifested in ways that include lingering near exit doors and/or mimicking or "shadowing" the exiting behavior of others who depart through this door. Referenced as...
Eligibility Criteria
Inclusion
- veterans age 60 and over with an Alzheimer's-like dementia diagnosis, documented in medical record with International Codes for Diagnosis (ICD-9) codes that include all 290 diagnoses and 331.0
- Mini Mental State Examination (MMSE) 24 or less
- evidence of pre-elopement behaviors operationalized as scoring 1 standard deviation (SD) above mean on any one of the three items that comprise the Revised Algase Wandering Scale-Community Version (RAWS-CV) eloping subscale (#16 - He/she attempts to get outside; #27- He/she stands at the out door wanting to go out; #30- He/she attempts to find or go to familiar locations, even unrealistic ones)
- living in a non-institutional private family home or foster home
- independently ambulatory (with or without canes, walkers or wheelchairs to assist)
- living within a 60-mile radius of the James A. Haley Veterans Administration Medical Center (VAMC), Tampa, Florida
- living with a caregiver (CG) who is willing and able to serve as a study partner and provide informant reports, and who intends to be with the PDW for three months (allowing for being away for seven days or less during the three-month study period)
- English speaking.
Exclusion
- living in a nursing home, group home or assisted living facility at point of entry (foster homes allowed)
- previous exposure to any visual exit barrier for wandering management
- no live-in CG
- bilaterally deaf or blind
- currently taking anti-psychotic medications
- current use of any visual exit barrier on any main exit doorway. CG will be allowed to use other wandering management interventions that are not specific to the exit doorways. For example, they may use a stop sign at the entrance to the kitchen, but may not use a stop sign on an experimentally monitored door.
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT00997425
Start Date
October 1 2009
End Date
December 1 2012
Last Update
November 21 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
James A Haley Veterans' Hospital
Tampa, Florida, United States, 33637-1022